Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

EGFR inhibitors for lung cancer can cause severe skin issues.

Tigason improved hair growth in a boy with monilethrix without side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib taken by mouth helps treat hair loss in children.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

Promising cancer treatments were found, but the manufacturer closed.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.